Andersen-Tawil syndrome: An ever-expanding phenotype?

Heart Rhythm

Volumn 3, Issue 11, 2006, Pages 1351-1352

  Tristani Firouzi, Martin ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNJ2; PROTEIN SCN5A; UNCLASSIFIED DRUG;

ANDERSEN-TAWIL SYNDROME; AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; CRANIOFACIAL MALFORMATION; EDITORIAL; ELECTROCARDIOGRAPHY; GENE MUTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; QT PROLONGATION; SKELETAL MUSCLE; SKELETON MALFORMATION; TOOTH MALFORMATION;

ANDERSEN SYNDROME; ELECTROCARDIOGRAPHY, AMBULATORY; GENETIC PREDISPOSITION TO DISEASE; HEART RATE; HUMANS; MUTATION, MISSENSE; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 33750290901     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.08.015     Document Type: Editorial

References (9)

1. Plaster N.M., Tawil R., Tristani-Firouzi M., Canun S., Bendahhou S., Tsunoda A., Donaldson M.R., Iannaccone S.T., Brunt E., Barohn R., Clark J., Deymeer F., George Jr. A.L., Fish F.A., Hahn A., Nitu A., Ozdemir C., Serdaroglu P., Subramony S.H., Wolfe G., Fu Y.H., and Ptacek L.J. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 (2001) 511-519
2. Tristani-Firouzi M., Jensen J.L., Donaldson M.R., Sansone V., Meola G., Hahn A., Bendahhou S., Kwiecinski H., Fidzianska A., Plaster N., Fu Y.H., Ptacek L.J., and Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110 (2002) 381-388
3. Zhang L., Benson D.W., Tristani-Firouzi M., Ptacek L.J., Tawil R., Schwartz P.J., George A.L., Horie M., Andelfinger G., Snow G.L., Fu Y.H., Ackerman M.J., and Vincent G.M. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 111 (2005) 2720-2726
4. Chun T.U., Epstein M.R., Dick II M., Andelfinger G., Ballester L., Vanoye C.G., George Jr. A.L., and Benson D.W. Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm 1 (2004) 235-241
5. Venance S.L., Cannon S.C., Fialho D., Fontaine B., Hanna M.G., Ptacek L.J., Tristani-Firouzi M., Tawil R., and Griggs R.C. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 129 (2006) 8-17
6. Andelfinger G., Tapper A.R., Welch R.C., Vanoye C.G., George Jr. A.L., and Benson D.W. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71 (2002) 663-668
7. Yoon G., Oberoi S., Tristani-Firouzi M., Etheridge S.P., Quitania L., Kramer J.H., Miller B.L., Fu Y.H., and Ptacek L.J. Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype. Am J Med Genet A 140 (2006) 312-321
8. Schoonderwoerd B.A., Wiesfeld A.C.P., Wilde A.A.M., van den Heuvel F., Van Tintelen J.P., van den Berg M.P., Van Veldhuisen D.J., and Van Gelder I.C. A family with Andersen-Tawil syndrome and dilated cardiomyopathy. Heart Rhythm 3 (2006) 1346-1350
9. Olson T.M., Michels V.V., Ballew J.D., Reyna S.P., Karst M.L., Herron K.J., Horton S.C., Rodeheffer R.J., and Anderson J.L. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293 (2005) 447-454